CANCER DENTAL
Mca09-004	Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis due to radiotherapy for head and neck cancer
	Quote:	Conclusion Daily intraoral PBM therapy using an LED-based device was safe, well tolerated, and significantly reduced the incidence of severe OM and associated complications in HNC patients undergoing IMRT with or without concurrent chemotherapy. These findings align with guidelines recommending daily intraoral PBM therapy for preventing cancer therapy-related OM, a dose-limiting toxicity for which effective preventive interventions are needed.
	Abstract:	https://www.medrxiv.org/content/10.64898/2026.02.26.26347195v1
	Full Text:	https://www.medrxiv.org/content/10.64898/2026.02.26.26347195v1.full-text
	Search Similar:	Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho
	Search Authors:	Kenneth Hu Pratish Shah M. Connie Nguyen Cornelia McCluskey Anne Kane Roger Ove Christopher D. Willey Sanford Katz Omkar Marathe Sasha Valentin Jennifer Frustino Alessandro Villa Sharon Spencer Catherine Holtzapfel Nathaniel Treister Rajesh V. Lalla,

Javilk's Research Links for Week 09
Updated 03/07/2026-12:02:44 AM
What interests you? What have you found? Tell me!
Drop me a note to subscribe or submit something.

Mca09-004

Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis due to radiotherapy for head and neck cancer